The Dow Jones closed lower by more than 500 points on Wednesday. Investors, meanwhile, focused on some notable insider trades.
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.3
Black Diamond Therapeutics
- The Trade: Black Diamond Therapeutics, Inc. BDTX 10% owner BB Biotech AG bought a total of 99,801 shares at an average price of $2.25. To acquire these shares, it cost around $224.91 thousand.
- What’s Happening: Black Diamond Therapeutics, during August, posted a Q2 loss of $0.63 per share.
- What Black Diamond Therapeutics Does: Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies.
Taysha Gene Therapies
- The Trade: Taysha Gene Therapies, Inc. TSHA Director Paul Manning acquired a total of 1,500,000 shares at an average price of $2.00. The insider spent around $3 million to buy those shares.
- What’s Happening: Taysha Gene Therapies recently priced a 14 million share public offering of common stock at $2 per share.
- What Taysha Gene Therapies Does: Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease.
Qualcomm To $170? These Analysts Slash Price Targets On Qualcomm Following Q3 Results
Don’t forget to check out our premarket coverage here .
TransAct Technologies
- The Trade: TransAct Technologies Incorporated TACT 10% owner Bryant Riley acquired a total of 7,994 shares at an average price of $3.95. To acquire these shares, it cost around $31.55 thousand.
- What’s Happening: TransAct was recently selected to provide printing solutions for The New Sky River Casino.
- What TransAct Technologies Does: Transact Technologies Inc develops and sells software-driven technology and printing solutions.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.